| Literature DB >> 35956304 |
Seán R Millar1, Pilar Navarro2, Janas M Harrington1, Ivan J Perry1, Catherine M Phillips1,2.
Abstract
Low-grade systemic inflammation is associated with a range of conditions. Diet may modulate inflammation and public health strategies are needed to guide consumers' dietary choices and help prevent diet-related disease. The Food Standards Agency nutrient profiling system (FSAm-NPS) constitutes the basis of the five-colour front-of-pack Nutri-Score labelling system. No study to date has examined FSAm-NPS dietary index associations with biomarkers of inflammation. Therefore, our objective was to test relationships between the FSAm-NPS and a range of inflammatory biomarkers in a cross-sectional sample of 2006 men and women aged 46-73 years. Individual participant FSAm-NPS scores were derived from food frequency questionnaires. Pro-inflammatory cytokine, adipocytokine, acute-phase response protein, coagulation factor and white blood cell count concentrations were determined. Correlation and linear regression analyses were used to examine FSAm-NPS relationships with biomarker levels. In crude and adjusted analyses, higher FSAm-NPS scores, reflecting poorer nutritional quality, were consistently and positively associated with biomarkers. In fully adjusted models, significant associations with concentrations of complement component 3, c-reactive protein, interleukin 6, tumour necrosis factor alpha, resistin, white blood cell count, neutrophils, eosinophils and the neutrophil-to-lymphocyte ratio persisted. These results suggest that dietary quality, determined by Nutri-Score rating, is associated with inflammatory biomarkers related to health.Entities:
Keywords: biomarkers; chronic; diet; inflammation; nutri-score
Mesh:
Substances:
Year: 2022 PMID: 35956304 PMCID: PMC9370507 DOI: 10.3390/nu14153122
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 6.706
Descriptive characteristics and inflammatory profiles of the study population according to FSAm-NPS dietary index quartiles.
| Variable | FSAm-NPS Dietary Index Quartiles (n = 2006) | ||||
|---|---|---|---|---|---|
| Q1 | Q2 | Q3 | Q4 |
| |
| Age (median) | 59.6 (55.0–64.0) | 59.2 (54.0–63.5) | 59.0 (54.0–63.5) | 59.0 (54.0–64.0) | 0.053 |
| Male (%) | 198 (39.4) | 221 (44.1) | 261 (52.1) | 303 (60.4) | <0.001 |
| Primary education only (%) | 126 (26.9) | 131 (27.6) | 122 (26.1) | 148 (31.2) | 0.219 |
| On anti-inflammatory medications (%) | 96 (19.5) | 86 (17.6) | 86 (17.6) | 67 (13.6) | 0.019 |
| Type 2 diabetes (%) | 53 (10.6) | 44 (8.8) | 44 (8.8) | 39 (7.8) | 0.143 |
| Current smoker (%) | 63 (12.8) | 64 (13.0) | 85 (17.1) | 77 (15.4) | 0.091 |
| Low-level physical activity (%) | 191 (40.4) | 225 (46.1) | 244 (51.6) | 257 (55.4) | <0.001 |
| BMI, kg/m2 (mean) | 28.3 ± 4.6 | 28.7 ± 4.8 | 28.7 ± 4.7 | 28.6 ± 4.8 | 0.329 |
| C3, mg/dL (mean) | 133.43 ± 25.4 | 136.53 ± 23.5 | 137.18 ± 24.5 | 136.20 ± 25.2 | 0.073 |
| CRP, ng/mL (median) | 1.26 (0.93–2.13) | 1.36 (0.98–2.32) | 1.38 (0.98–2.33) | 1.41 (0.99–2.36) | 0.01 |
| IL-6, pg/mL (median) | 1.61 (1.14–2.72) | 1.77 (1.17–2.85) | 1.82 (1.18–2.95) | 1.96 (1.30–3.09) | <0.001 |
| TNF-α, pg/mL (median) | 4.78 (4.74–7.22) | 5.91 (4.80–7.29) | 6.03 (4.95–7.32) | 6.22 (5.11–7.36) | 0.003 |
| Adiponectin, ng/mL (median) | 5.42 (3.15–8.31) | 4.83 (3.00–7.70) | 4.73 (2.93–7.50) | 4.00 (2.73–6.63) | <0.001 |
| Leptin, ng/mL (median) | 2.00 (1.12–3.21) | 2.00 (1.03–3.35) | 1.98 (1.19–3.31) | 1.71 (1.00–2.83) | 0.46 |
| Resistin, ng/mL (median) | 5.06 (3.90–6.66) | 5.00 (3.95–6.65) | 4.92 (3.90–6.70) | 5.20 (3.92–6.92) | 0.377 |
| PAI-1, ng/mL (mean) | 27.17 ± 13.8 | 26.66 ± 11.2 | 27.87 ± 12.5 | 27.98 ± 12.6 | 0.153 |
| WBC, 109/L (median) | 5.40 (4.70–6.50) | 5.70 (4.70–6.70) | 5.70 (4.90–7.00) | 5.90 (5.00–7.00) | <0.001 |
| Neutrophils, 10⁹/L (median) | 2.97 (2.39–3.76) | 3.09 (2.46–3.87) | 3.18 (2.53–4.00) | 3.26 (2.70–4.17) | <0.001 |
| Lymphocytes, 10⁹/L (median) | 1.73 (1.42–2.12) | 1.74 (1.44–2.15) | 1.76 (1.41–2.14) | 1.75 (1.43–2.17) | 0.32 |
| NLR (median) | 1.73 (1.32–2.24) | 1.74 (1.36–2.23) | 1.76 (1.41–2.31) | 1.86 (1.48–2.38) | <0.001 |
| Monocytes, 10⁹/L (median) | 0.48 (0.38–0.59) | 0.49 (0.39–0.60) | 0.50 (0.41–0.63) | 0.52 (0.43–0.65) | <0.001 |
| Eosinophils, 10⁹/L (median) | 0.16 (0.11–0.25) | 0.17 (0.10–0.25) | 0.18 (0.12–0.27) | 0.18 (0.12–0.27) | 0.005 |
| Basophils, 10⁹/L (median) | 0.031 (0.02–0.04) | 0.032 (0.02–0.04) | 0.033 (0.02–0.04) | 0.033 (0.02–0.04) | 0.129 |
Abbreviations: BMI: body mass index; C3: complement component 3; CRP: c-reactive protein; FSAm-NPS: Food Standards Agency nutrient profiling system; IL-6: interleukin 6; TNF-α: tumour necrosis factor alpha; PAI-1: plasminogen activator inhibitor 1; WBC: white blood cell count; NLR: neutrophil-to-lymphocyte ratio. p for trend determined from a Jonckheere test, a linear-by-linear chi-square or an ANOVA.
Nutritional intake of the study population according to FSAm-NPS dietary index quartiles.
| Variable | FSAm-NPS Dietary Index Quartiles (n = 2006) | ||||
|---|---|---|---|---|---|
| Q1 | Q2 | Q3 | Q4 |
| |
|
| |||||
| Energy intake, kcal (mean) | 1808.8 ± 740.0 | 1975.4 ± 752.7 | 2133.7 ± 835.7 | 2211.3 ± 874.4 | <0.001 |
| Fat, g/d (mean) | 60.1 ± 29.6 | 72.5 ± 32.7 | 82.5 ± 37.5 | 93.8 ± 42.4 | <0.001 |
| SFA, g/d (mean) | 18.1 ± 8.7 | 23.3 ± 11.1 | 28.6 ± 13.0 | 38.0 ± 17.1 | <0.001 |
| PUFA, g/d (mean) | 13.6 ± 9.4 | 15.5 ± 8.4 | 16.7 ± 9.7 | 16.1 ± 9.7 | <0.001 |
| MUFA, g/d (mean) | 19.3 ± 9.9 | 23.2 ± 10.8 | 26.1 ± 12.3 | 28.6 ± 13.3 | <0.001 |
| Carbohydrate, g/d (mean) | 232.5 ± 106.9 | 246.1 ± 104.5 | 259.3 ± 112.0 | 260.2 ± 115.7 | <0.001 |
| Protein, g/d (mean) | 90.6 ± 41.0 | 90.8 ± 33.1 | 95.1 ± 37.3 | 90.6 ± 38.8 | 0.556 |
| Sugar, g/d (mean) | 101.7 ± 64.8 | 105.3 ± 56.1 | 106.4 ± 53.4 | 108.1 ± 61.8 | 0.086 |
| Alcohol, ml/d (mean) | 5.3 ± 11.7 | 5.8 ± 10.9 | 6.0 ± 12.7 | 4.7 ± 10.0 | 0.483 |
| Fibre, g/d (mean) | 28.2 ± 13.9 | 26.6 ± 12.2 | 25.8 ± 11.8 | 23.6 ± 10.3 | <0.001 |
|
| |||||
| Bread, cereal, potatoes, grains and rice (mean) | 5.1 ± 3.0 | 5.2 ± 2.7 | 5.5 ± 3.3 | 5.4 ± 2.9 | 0.026 |
| Fruit and vegetables (mean) | 9.2 ± 6.9 | 7.7 ± 4.9 | 6.5 ± 4.0 | 5.2 ± 3.1 | <0.001 |
| Dairy (mean) | 1.7 ± 1.4 | 1.9 ± 1.4 | 2.1 ± 1.5 | 2.0 ± 1.6 | <0.001 |
| Meat, fish, poultry and eggs (mean) | 2.3 ± 1.3 | 2.4 ± 1.2 | 2.5 ± 1.3 | 2.4 ± 1.4 | 0.026 |
| Fats, high fat/sugar foods and drinks (mean) | 4.6 ± 2.9 | 7.1 ± 4.0 | 8.4 ± 4.5 | 11.5 ± 5.7 | <0.001 |
Abbreviations: FSAm-NPS: Food Standards Agency nutrient profiling system; MUFA: monounsaturated fatty acids; PUFA: polyunsaturated fatty acids; SFA: saturated fatty acids. p for trend determined from an ANOVA.
Spearman correlation coefficients between the FSAm-NPS dietary index and inflammatory and thrombotic biomarkers.
| Biomarker | Correlation Coefficients |
|
|---|---|---|
| C3, mg/dL | 0.047 | 0.039 |
| CRP, ng/mL | 0.060 | 0.008 |
| IL-6, pg/mL | 0.074 | 0.001 |
| TNF-α, pg/mL | 0.078 | 0.001 |
| Adiponectin, ng/mL | −0.115 | <0.001 |
| Leptin, ng/mL | −0.037 | 0.099 |
| Resistin, ng/mL | 0.032 | 0.162 |
| PAI-1, ng/mL | 0.039 | 0.086 |
| WBC, 109/L | 0.104 | <0.001 |
| Neutrophils, 10⁹/L | 0.116 | <0.001 |
| Lymphocytes, 10⁹/L | 0.014 | 0.525 |
| NLR | 0.088 | <0.001 |
| Monocytes, 10⁹/L | 0.107 | <0.001 |
| Eosinophils, 10⁹/L | 0.069 | 0.002 |
| Basophils, 10⁹/L | 0.036 | 0.115 |
Values are presented as Spearman correlation coefficients between the FSAm-NPS dietary index and inflammatory and thrombotic biomarkers among the Mitchelstown cohort (n = 2006).
Linear regression analysis of the associations between the FSAm-NPS dietary index and inflammatory and thrombotic biomarkers (n = 2006).
| Biomarker | Model 1 | Model 2 | Model 3 | Model 4 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| β | S.E. |
| β | S.E. |
| β | S.E. |
| β | S.E. |
| |
| C3 | 1.330 | 0.558 |
| 1.654 | 0.564 |
| 1.666 | 0.591 |
| 1.767 | 0.571 |
|
| Log CRP | 0.045 | 0.016 |
| 0.055 | 0.016 |
| 0.048 | 0.017 |
| 0.047 | 0.016 |
|
| Log IL-6 | 0.051 | 0.017 |
| 0.045 | 0.017 |
| 0.043 | 0.018 |
| 0.042 | 0.017 |
|
| Log TNF-α | 0.023 | 0.008 |
| 0.021 | 0.008 |
| 0.021 | 0.009 |
| 0.023 | 0.009 |
|
| Log Adiponectin | −0.083 | 0.016 |
| −0.026 | 0.014 | 0.06 | −0.025 | 0.015 | 0.082 | −0.025 | 0.015 | 0.081 |
| Log Leptin | −0.026 | 0.021 | 0.215 | 0.013 | 0.020 | 0.532 | 0.015 | 0.021 | 0.476 | 0.017 | 0.018 | 0.354 |
| Log Resistin | 0.020 | 0.010 |
| 0.026 | 0.010 |
| 0.027 | 0.010 |
| 0.029 | 0.010 |
|
| PAI-1 | 0.417 | 0.284 | 0.142 | 0.158 | 0.286 | 0.582 | 0.089 | 0.302 | 0.768 | 0.055 | 0.307 | 0.857 |
| Log WBC | 0.028 | 0.006 |
| 0.022 | 0.006 |
| 0.017 | 0.007 |
| 0.016 | 0.006 |
|
| Log Neutrophils | 0.037 | 0.008 |
| 0.030 | 0.008 |
| 0.025 | 0.008 |
| 0.024 | 0.008 |
|
| Log Lymphocytes | 0.006 | 0.007 | 0.421 | 0.006 | 0.007 | 0.462 | 0.002 | 0.008 | 0.757 | 0.002 | 0.008 | 0.775 |
| Log NLR | 0.031 | 0.009 |
| 0.024 | 0.009 |
| 0.023 | 0.009 |
| 0.021 | 0.010 |
|
| Log Monocytes | 0.038 | 0.007 |
| 0.024 | 0.007 |
| 0.017 | 0.008 |
| 0.014 | 0.007 | 0.067 |
| Log Eosinophils | 0.046 | 0.014 |
| 0.033 | 0.014 |
| 0.035 | 0.015 |
| 0.037 | 0.015 |
|
| Log Basophils | 0.018 | 0.013 | 0.163 | 0.019 | 0.013 | 0.145 | 0.019 | 0.014 | 0.163 | 0.013 | 0.014 | 0.341 |
Model 1: univariate. Model 2: adjusted for age and sex. Model 3: adjusted for age, sex, anti-inflammatory medication use and physical activity. Model 4: adjusted for age, sex, anti-inflammatory medication use, physical activity, education, smoking, type 2 diabetes and BMI. Unstandardised β coefficients and standard errors (S.E.) are shown. Significant p in bold.